Stock UTMD UTAH MEDICAL PRODUCTS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Utah Medical Products, Inc.

Equities

UTMD

US9174881089

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
65.92 USD -0.56% Intraday chart for Utah Medical Products, Inc. -3.88% -21.73%
Apr. 25 Utah Medical Products, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Reports Q1 Revenue $11.3M MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 310.2 401.5 306.9 365.1 364.7 305.7
Enterprise Value (EV) 1 259.1 359.1 255.7 304.6 290 213.2
P/E ratio 16.8 x 27.4 x 28.7 x 24.7 x 22.2 x 18.4 x
Yield 1.31% 1.02% 1.33% 0.86% 1.16% 1.41%
Capitalization / Revenue 7.39 x 8.56 x 7.28 x 7.44 x 6.98 x 6.09 x
EV / Revenue 6.17 x 7.66 x 6.06 x 6.21 x 5.55 x 4.24 x
EV / EBITDA 12 x 14.7 x 12.2 x 11.6 x 10.6 x 8.61 x
EV / FCF 18.9 x -46.8 x 15.2 x 17.8 x 15.5 x 12.1 x
FCF Yield 5.29% -2.14% 6.57% 5.62% 6.45% 8.28%
Price to Book 3.47 x 3.97 x 2.99 x 3.41 x 3.19 x 2.38 x
Nbr of stocks (in thousands) 3,734 3,721 3,640 3,651 3,628 3,630
Reference price 2 83.08 107.9 84.30 100.0 100.5 84.22
Announcement Date 3/14/19 3/16/20 3/26/21 3/25/22 3/27/23 3/26/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 42 46.9 42.18 49.05 52.28 50.22
EBITDA 1 21.64 24.49 20.88 26.18 27.49 24.75
EBIT 1 18.69 17.65 13.71 18.9 20.46 18.44
Operating Margin 44.5% 37.63% 32.5% 38.53% 39.13% 36.71%
Earnings before Tax (EBT) 1 19.46 17.88 13.84 19.06 20.66 20.09
Net income 1 18.56 14.73 10.8 14.79 16.47 16.64
Net margin 44.18% 31.4% 25.6% 30.15% 31.51% 33.12%
EPS 2 4.950 3.939 2.941 4.041 4.522 4.574
Free Cash Flow 1 13.72 -7.673 16.81 17.1 18.71 17.65
FCF margin 32.67% -16.36% 39.84% 34.86% 35.8% 35.13%
FCF Conversion (EBITDA) 63.39% - 80.49% 65.32% 68.08% 71.29%
FCF Conversion (Net income) 73.95% - 155.64% 115.65% 113.61% 106.08%
Dividend per Share 2 1.085 1.105 1.120 0.8550 1.165 1.185
Announcement Date 3/14/19 3/16/20 3/26/21 3/25/22 3/27/23 3/26/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 51.1 42.4 51.2 60.5 74.7 92.5
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 13.7 -7.67 16.8 17.1 18.7 17.6
ROE (net income / shareholders' equity) 22.2% 15.5% 10.6% 14.1% 14.9% 13.7%
ROA (Net income/ Total Assets) 12.1% 10.5% 7.73% 10.4% 10.7% 8.89%
Assets 1 152.9 139.9 139.6 142.3 154.3 187.2
Book Value Per Share 2 23.90 27.20 28.20 29.30 31.50 35.40
Cash Flow per Share 2 13.70 11.50 14.20 16.70 20.70 25.60
Capex 1 0.4 0.54 0.86 0.55 0.81 0.64
Capex / Sales 0.96% 1.15% 2.04% 1.13% 1.55% 1.27%
Announcement Date 3/14/19 3/16/20 3/26/21 3/25/22 3/27/23 3/26/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
UTAH MEDICAL PRODUCTS, INC. Stock Utah Medical Products, Inc.
-21.73% 237M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. UTMD Stock
  4. Financials Utah Medical Products, Inc.